Literature DB >> 6975191

Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficient-severe combined immunodeficiency.

H Ratech, R Hirschhorn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975191     DOI: 10.1016/0009-8981(81)90247-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  5 in total

1.  Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses.

Authors:  B A Conlon; W R Law
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

2.  Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells.

Authors:  Yuliia Kaljas; Chengqian Liu; Maksym Skaldin; Chengxiang Wu; Qing Zhou; Yuanan Lu; Ivona Aksentijevich; Andrey V Zavialov
Journal:  Cell Mol Life Sci       Date:  2016-09-23       Impact factor: 9.261

3.  Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections.

Authors:  I Tsuboi; K Sagawa; S Shichijo; M M Yokoyama; D W Ou; M D Wiederhold
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

4.  Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity.

Authors:  Jae-Geun Lee; Dong Gu Kang; Jung Re Yu; Youngree Kim; Jinsoek Kim; Gwanpyo Koh; Daeho Lee
Journal:  Diabetes Metab J       Date:  2011-04-30       Impact factor: 5.376

5.  Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life.

Authors:  Oludare A Odumade; Alec L Plotkin; Jensen Pak; Olubukola T Idoko; Matthew A Pettengill; Tobias R Kollmann; Al Ozonoff; Beate Kampmann; Ofer Levy; Kinga K Smolen
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.